ACE2 and metabolic dysfunction-associated steatotic liver disease: Overexpression of the ACE2 protein activates the AMPK/mTOR pathway, modulates HSCs autophagy, suppresses HSCs activation, and decelerates the progression of liver fibrosis in individuals with NAFLD.